31 – 40 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF
(
- Contribution to journal › Article
- 2003
-
Mark
Cerebral pattern of pro- and anti-inflammatory cytokines in dementias
(
- Contribution to journal › Article
-
Mark
Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
(
- Contribution to journal › Article
-
Mark
Increased frequency of a new polymorphism in the cycle 2 (cdc2) gene in patients with Alzheimer's disease frontotemporal dementia
(
- Contribution to journal › Article
- 2002
-
Mark
Productivity scenarios for the Asa Forest Park
2002) p.355-380(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors
(
- Contribution to journal › Article
- 2001
-
Mark
Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry
(
- Contribution to journal › Article